HK1210591A1 - High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms - Google Patents

High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Info

Publication number
HK1210591A1
HK1210591A1 HK15111340.7A HK15111340A HK1210591A1 HK 1210591 A1 HK1210591 A1 HK 1210591A1 HK 15111340 A HK15111340 A HK 15111340A HK 1210591 A1 HK1210591 A1 HK 1210591A1
Authority
HK
Hong Kong
Prior art keywords
preparation
dosage forms
solid dosage
high content
preparing non
Prior art date
Application number
HK15111340.7A
Other languages
English (en)
Chinese (zh)
Inventor
．布頓
．蘭貝思
．利馬塔
帕特里克．
．胡
Original Assignee
Si Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49841833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210591(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/714,768 external-priority patent/US9629809B2/en
Application filed by Si Group Inc filed Critical Si Group Inc
Publication of HK1210591A1 publication Critical patent/HK1210591A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK15111340.7A 2012-12-14 2015-11-17 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms HK1210591A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/714,768 US9629809B2 (en) 2008-07-21 2012-12-14 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
PCT/US2013/072981 WO2014093073A1 (en) 2012-12-14 2013-12-04 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Publications (1)

Publication Number Publication Date
HK1210591A1 true HK1210591A1 (en) 2016-04-29

Family

ID=49841833

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111340.7A HK1210591A1 (en) 2012-12-14 2015-11-17 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Country Status (9)

Country Link
EP (1) EP2931261A1 (xx)
JP (1) JP6285952B2 (xx)
CN (1) CN104884048B (xx)
BR (1) BR112015013945A8 (xx)
CA (1) CA2894272A1 (xx)
CL (1) CL2015001621A1 (xx)
HK (1) HK1210591A1 (xx)
MX (1) MX2015007571A (xx)
WO (1) WO2014093073A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043614A1 (en) 2017-08-31 2019-03-07 Novartis Ag PROCESS FOR THE PREPARATION OF GRANULES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
JP4753567B2 (ja) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 付着性の高い薬物を含有する錠剤の製造方法
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
JP5553830B2 (ja) * 2008-07-21 2014-07-16 アルベマール・コーポレーシヨン 高含量イブプロフェンナトリウム顆粒、その調製、および非発泡性固体剤形を調製する際のその使用
MX2020011961A (es) * 2010-03-24 2022-04-19 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.

Also Published As

Publication number Publication date
JP2016508124A (ja) 2016-03-17
BR112015013945A8 (pt) 2019-10-08
CN104884048B (zh) 2018-11-23
WO2014093073A1 (en) 2014-06-19
CA2894272A1 (en) 2014-06-19
MX2015007571A (es) 2016-04-15
CN104884048A (zh) 2015-09-02
JP6285952B2 (ja) 2018-02-28
BR112015013945A2 (pt) 2017-07-11
EP2931261A1 (en) 2015-10-21
CL2015001621A1 (es) 2015-08-07

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
HRP20181172T1 (hr) Derivati pirazolpirimidina supstituirani na poziciji 4, te njihova uporaba u proizvodnji lijekova
IL231382A0 (en) History of benzonitriles, their preparation containing them
IL231386A0 (en) Pyrazoloquinolinone derivatives, their preparation and medical use
EP2881395A4 (en) PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT
IL235414A (en) The history of pyrolotriazinone, their preparation and their pharmaceutical preparations
SI2655375T1 (sl) Derivati pirimidinona, njihova priprava in njihova farmacevtska uporaba
HK1222563A1 (zh) 藥物組合物、製備及其用途
EP2939662A4 (en) TEMOCOLOMIDE-CONTAINING PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AND METHOD OF MANUFACTURING THEREOF
IL233602A (en) The history of benzamide, their preparation and their pharmaceutical preparations
SG11201602935PA (en) Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
IL237322A0 (en) Solid pharmaceutical preparations containing levothyroxine and their preparation
IL233825A (en) H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1211570A1 (en) Indene derivatives, their preparation and use as medicaments
EP2865666A4 (en) HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE
IL246297A0 (en) History of pyrazine, their preparation and pharmaceutical preparations containing them
HK1204613A1 (en) Substituted pyrano and furanoquinolines, their preparation and use as medicaments
HK1210591A1 (en) High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2926811A4 (en) ARTEMISCULAR PHARMACEUTICAL COMPOSITION, MANUFACTURE AND USE
EP2844661A4 (en) FUSIONED HETEROCYCLE MORPHINANES, THEIR USE AND PREPARATION THEREOF
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
EP2882801C0 (en) CONDUCTIVE POLYMER MATERIALS, THEIR PRODUCTION AND USE
HK1201179A1 (en) Antacid tablet
SG11201406583QA (en) Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spi